| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.003 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.09 | 0.003 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.51 | 0.004 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.39 | 0.004 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |